Delay on Rule That Would Eliminate Medicare Part D Drug Rebates
On January 29, 2021, the Biden Administration delayed implementation of a recently adopted rule that would largely eliminate drug rebates…
Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).
Timothy Doyle Joins Breakthrough T1D as President and Chief Operating Officer
Doyle will lead organizational operations to broaden Breakthrough T1D’s reach and impact.
Department of Health & Human Services Freezes Rule Related to Insulin
As you may have heard from reports in the media the Biden Administration froze a recent regulation on insulin. Want to know what the headlines mean? Read on to get…
Why Does One Scientist Seek to Find Cures for T1D? Answer: His Children
Douglas Melton, Ph.D., can now produce unlimited quantities of beta cells. He now wants to evade the immune attack. See…
COVID-19 Vaccine Access Guide
Breakthrough T1D has been closely monitoring the data on how COVID-19 affects people with T1D and new information about the…
It’s Official: Teplizumab is Under Review by the FDA
The FDA regulatory review is now under way for teplizumab, to prevent or delay T1D in at-risk individuals. The target…
What We Can Be Proud Of in 2020
It’s been a tough year, to say the least. But there’s news that we can be proud of in type…
Breakthrough T1D Video: “Wouldn’t Have Happened Without Breakthrough T1D”
Dr. Robert Langer co-founded Moderna, who gained emergency use approval for its COVID vaccine. Watch the video to find out…
Discovery to Translation: Clinical Trial of a JAK Inhibitor in T1D
A Breakthrough T1D-funded clinical trial will test if a JAK inhibitor will preserve beta cell function in children and young…
